Non Invasive Neurostimulation Devices Market Report 2026

Non Invasive Neurostimulation Devices Market Overview

• Non Invasive Neurostimulation Devices market size has reached to $1.89 billion in 2025 • Expected to grow to $3.45 billion in 2030 at a compound annual growth rate (CAGR) of 12.7% • Growth Driver: Increasing Prevalence Of Neurological Disorders Fueling The Growth Of The Market Due To Rising Diagnostic And Therapeutic Demand • Market Trend: Remote Brain Stimulation Expands Access To At-Home Therapy • North America was the largest region in 2025.

What Is Covered Under Non Invasive Neurostimulation Devices Market?

Non-invasive neurostimulation devices are medical technologies designed to modulate neural activity without surgical intervention. They use external methods such as electrical, magnetic, or ultrasonic stimulation to target specific areas of the nervous system. The primary purpose is to manage neurological and psychiatric conditions such as chronic pain, depression, or epilepsy by altering brain or nerve function safely and effectively. The main types of non invasive neurostimulation devices are transcutaneous electrical nerve stimulation (TENS), transcranial magnetic stimulation (TMS), electromagnetic stimulation (EMS), and others. Transcutaneous electrical nerve stimulation (TENS) refers to a non-invasive method of pain relief that involves delivering low-voltage electrical impulses through the skin using electrodes. These devices are used for various indications, including pain management, neurological disorders, psychological disorders, and others, serving a range of end users, such as hospitals and clinics, homecare environments, and research and academic institutes.

What Is The Non Invasive Neurostimulation Devices Market Growth Forecast?

The non invasive neurostimulation devices market size is expected to see rapid growth in the next few years. It will grow to $3.45 billion in 2030 at a compound annual growth rate (CAGR) of 12.7%. The growth in the forecast period can be attributed to technological advancements in tDCS and EMS devices, rising prevalence of chronic pain and neurological disorders, growing adoption of homecare neurostimulation solutions, increasing investment in clinical research and academic studies, integration of AI and smart monitoring in neurostimulation devices. Major trends in the forecast period include rising adoption of non-invasive pain management therapies, expansion of homecare neurostimulation devices, integration of wearable and portable neurostimulation solutions, increasing clinical research and academic studies on neurostimulation, focus on personalized and targeted neurostimulation treatments.

Global Non Invasive Neurostimulation Devices Market Segmentation

1) By Type Of Stimulation Technology: Transcutaneous Electrical Nerve Stimulation (TENS), Transcranial Magnetic Stimulation (TMS), Electromagnetic Stimulation (EMS), Other Types Of Stimulation Technologies 2) By Target Indication: Pain Management, Neurological Disorders, Psychological Disorder, Other Target Indications 3) By End User: Hospitals And Clinics, Homecare Settings, Research And Academic Institutes Subsegments: 1) By Transcutaneous Electrical Nerve Stimulation (TENS): Conventional Transcutaneous Electrical Nerve Stimulation (TENS), Acupuncture-Like Transcutaneous Electrical Nerve Stimulation (TENS), Brief-Intense Transcutaneous Electrical Nerve Stimulation (TENS), Burst Mode Transcutaneous Electrical Nerve Stimulation (TENS) 2) By Transcranial Magnetic Stimulation (TMS): Repetitive Transcranial Magnetic Stimulation (rTMS), Deep Transcranial Magnetic Stimulation (dTMS), Single-Pulse Transcranial Magnetic Stimulation, Paired-Pulse Transcranial Magnetic Stimulation 3) By Electromagnetic Stimulation (EMS): Functional Electromagnetic Stimulation (EMS), Neuromuscular Electromagnetic Stimulation (EMS), High-Frequency Electromagnetic Stimulation (EMS), Low-Frequency Electromagnetic Stimulation (EMS) 4) By Other Types Of Stimulation Technology: Transcranial Direct Current Stimulation (tDCS), Cranial Electrotherapy Stimulation (CES)

What Is The Driver Of The Non Invasive Neurostimulation Devices Market?

The increasing prevalence of neurological disorders is expected to propel the growth of the non invasive neurostimulation devices market going forward. Neurological disorders are medical conditions that affect the brain, spinal cord and nerves, leading to a range of symptoms including cognitive, motor, and sensory impairments. The increasing prevalence of neurological disorders is linked to the aging global population, as aging gradually impairs neuronal function, reduces brain plasticity, and elevates oxidative stress, contributing to the development and progression of these conditions. Non-invasive neurostimulation devices aid in diagnosing neurological disorders by delivering targeted stimulation to assess neural responses. They offer non-surgical, real-time evaluation methods, enhancing diagnostic accuracy and improving patient care in clinical and home settings. For instance, in July 2024, according to the National Health Service, a UK-based government agency, there were 487,432 patients diagnosed with dementia (a progressive brain disorder affecting memory, thinking, and daily activities) by June 30, 2024, an increase of 3,155 cases compared to May 31, 2024. Therefore, the increasing prevalence of neurological disorders is driving the growth of the non invasive neurostimulation devices industry.

Key Players In The Global Non Invasive Neurostimulation Devices Market

Major companies operating in the non invasive neurostimulation devices market are Alpha Stim, Neurosoft Bioelectronics SA, Neuronetics Inc, BrainsWay Ltd, eNeura Inc, MagVenture A S, Nexstim Plc, Neuroelectrics Barcelona S L U, Cefaly Technology, ElectroCore Inc, Brainbox India Private Limited, Flow Neuroscience AB, Fisher Wallace Laboratories Inc, Sooma Medical, NeuroSigma Inc, Mind Alive Inc, TheBrainDriver LLC, Caputron Medical Products LLC, Soterix Medical Inc, neuroConn GmbH, Halo Neuroscience Inc, BTL Industries Inc, Zimmer MedizinSysteme GmbH

Global Non Invasive Neurostimulation Devices Market Trends and Insights

Major companies operating in the non invasive neurostimulation devices market are focusing on developing advanced products, such as personalized stimulation protocols, to enhance and improve treatment effectiveness and patient outcomes. Personalized stimulation protocols refer to tailored neurostimulation settings that are customized to an individual’s specific medical condition, neural response, and treatment goals, aiming to maximize therapeutic effectiveness and minimize side effects. For instance, in October 2023, Sooma Medical, a Finland-based medical technology company, launched a remote clinician-monitored brain stimulation system designed for at-home treatment using non-invasive transcranial direct current stimulation (tDCS). This innovative system allows healthcare professionals to remotely oversee therapy sessions, enhancing accessibility and adherence for patients with neurological and mental health conditions such as depression and chronic pain.

What Are Latest Mergers And Acquisitions In The Non Invasive Neurostimulation Devices Market?

In December 2024, ElectroCore Inc., a US-based medical technology company, acquired NeuroMetrix Inc. for an undisclosed amount. With this acquisition, ElectroCore expanded its portfolio in non-invasive neuromodulation by adding NeuroMetrix’s Quell pain relief device and DPNCheck diagnostic tool, enhancing its position in bioelectronic medicine. NeuroMetrix Inc. is a US-based neurotechnology company specializing in non-invasive neurostimulation devices.

Regional Outlook

North America was the largest region in the non invasive neurostimulation devices market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Non Invasive Neurostimulation Devices Market?

The non-invasive neurostimulation devices market consists of revenues earned by entities by providing services such as pain management therapy, cognitive enhancement programs, rehabilitation support, mental health treatment, and remote patient monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The non-invasive neurostimulation devices market also includes sales of transcranial magnetic stimulators (TMS), transcranial direct current stimulators (tDCS), vagus nerve stimulators (non-implantable), external trigeminal nerve stimulators (eTNS), and wearable neurostimulators. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.